CDER/GPhA workshop
This article was originally published in The Tan Sheet
Executive Summary
Regulatory issues involving generic drugs to be discussed at meeting at Hyatt Regency in Bethesda, Md. May 21. Presentations delivered by CDER and Generic Pharmaceuticals Association reps will run from 8 a.m. to 5 p.m. Office of Generic Drugs Acting Director Gary Buehler and GPhA President William Nixon are among those scheduled to speak
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning